文献速递甲状腺疾病

新生儿大分子促甲状腺激素的患病率与发病机制:939名新生儿及其母亲脐带血分析

Prevalence and Pathogenesis of Macro-Thyrotropin in Neonates: Analysis of Umbilical Cord Blood from 939 Neonates and Their Mothers.
PubMed 文献 · Thyroid · 2022-12-20

研究检测939份新生儿及母亲脐带血中大分子促甲状腺激素(macro-TSH),发现4名新生儿(0.43%)存在抗TSH自身抗体,其母亲也均存在,抗体可能经胎盘转移。作者建议当新生儿TSH升高而游离甲状腺素正常时,应检查母亲大分子促甲状腺激素。

要点

  • 新生儿大分子促甲状腺激素患病率为0.43%(4/939),其母亲均存在大分子促甲状腺激素。
  • 抗TSH自身抗体可能经胎盘从母亲转移至胎儿,与新生儿TSH结合形成大分子促甲状腺激素。
  • 作者建议新生儿TSH升高疑诊先天性甲状腺功能减退但游离甲状腺素正常时,应检查母亲大分子促甲状腺激素。

核心结论

  • 大分子促甲状腺激素在新生儿中患病率为0.43%,其母亲均存在大分子促甲状腺激素。
  • 作者建议若新生儿血清TSH浓度高到考虑左甲状腺素治疗并怀疑先天性甲状腺功能减退,但游离甲状腺素水平正常,应检查其母亲的大分子促甲状腺激素。

研究设计与样本

  • 研究检测939份新生儿及其母亲脐带血样本中大分子促甲状腺激素的存在。
  • 采用聚乙二醇沉淀法、凝胶过滤色谱法和125I-TSH结合研究进行检测。

主要发现

  • 138份血清样本TSH聚乙二醇沉淀率>68.9%(均值+标准差),其中9份发现人抗鼠抗体。
  • 剩余129份血清样本经125I-TSH结合研究,4名婴儿(0.43%)血清125I-TSH结合比值显著升高。
  • 4名婴儿中2名为同胞,其母亲及另外2名母亲也显示显著高结合比值。
  • 所有病例中,大量(1 μg)未标记人TSH可类似 displacing 婴儿与母亲的125I-TSH结合,提示血清中存在抗TSH自身抗体。
  • 对1名婴儿及其母亲的自身抗体进一步表征显示低亲和力、对人TSH高特异性,两者性质非常相似。

临床怎么用

  • 作者建议若新生儿血清TSH浓度高到考虑左甲状腺素治疗并怀疑先天性甲状腺功能减退,但游离甲状腺素水平正常,应检查其母亲的大分子促甲状腺激素。

局限性

  • 凝胶过滤色谱法仅在一名婴儿及其母亲中检测到大分子促甲状腺激素,可能因分析过程中TSH与自身抗体解离。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Macro-thyrotropin (macro-TSH) is a large molecular weight TSH that causes elevated serum TSH concentrations due to its slow clearance. It is primarily a complex of TSH and anti-TSH autoantibodies. The aims of this study were to examine the prevalence and nature of macro-TSH in neonates and to determine how to cope with macro-TSH in neonates suspected to have congenital hypothyroidism through neonatal mass screening. Methods: The presence of macro-TSH was examined using polyethylene glycol (PEG), gel filtration chromatography (GFC), and 125I-TSH binding studies in 939 umbilical cord blood samples from neonates and their mothers. Results: Among 138 serum samples with a PEG precipitation ratio of TSH >68.9% (mean + standard deviation), human anti-mouse antibodies were found in nine samples. The presence of macro-TSH was examined in the remaining 129 serum samples using a 125I-TSH binding study and GFC. The 125I-TSH binding study revealed that four babies (0.43%) had significantly high ratios of 125I-TSH binding to their sera. Two of the babies were siblings, and their mother and the other two mothers also showed significantly high binding ratios. The 125I-TSH binding was displaced by a large amount (1 μg) of unlabeled human TSH in a similar way between babies and their mothers in all cases, suggesting the presence of anti-TSH autoantibodies in their sera. Further characterization of the autoantibodies in one baby and its mother showed a low affinity and high specificity to human TSH, and the nature was very similar between them. These findings may indicate that the anti-TSH autoantibodies that developed in the mother were transferred to the baby through the placenta and formed macro-TSH by binding to neonatal TSH. GFC revealed macro-TSH in only one baby and its mother, probably because of the dissociation of TSH from autoantibodies during the analytical procedure. Conclusions: Macro-TSH was found in 0.43% of neonates, and their mothers all had macro-TSH as well. We recommend that if a baby's serum TSH concentration is high enough to consider levothyroxine treatment suspecting congenital hypothyroidism but the free thyroxine level is normal, their mother's macro-TSH should be checked.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Hattori N, Aisaka K, Yamada A, et al. Prevalence and Pathogenesis of Macro-Thyrotropin in Neonates: Analysis of Umbilical Cord Blood from 939 Neonates and Their Mothers. Thyroid. 2022. PMID: 36345221. doi:10.1089/thy.2022.0457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。